Gabelli & Co Investment Advisers’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-500
| Closed | -$237K | – | 341 |
|
|
2026
Q1 | $237K | Hold |
500
| – | – | 0.04% | 219 |
|
|
2025
Q4 | $233K | Hold |
500
| – | – | 0.04% | 210 |
|
|
2025
Q3 | $213K | Buy |
+500
| New | +$194K | 0.03% | 211 |
|
|
2024
Q4 | – | Sell |
-750
| Closed | -$305K | – | 255 |
|
|
2024
Q3 | $305K | Hold |
750
| – | – | 0.05% | 135 |
|
|
2024
Q2 | $241K | Sell |
750
-250
| -25% | -$81.2K | 0.04% | 179 |
|
|
2024
Q1 | $334K | Sell |
1,000
-500
| -33% | -$153K | 0.06% | 140 |
|
|
2023
Q4 | $406K | Buy |
1,500
+250
| +20% | +$61.8K | 0.08% | 132 |
|
|
2023
Q3 | $307K | Hold |
1,250
| – | – | 0.05% | 144 |
|
|
2023
Q2 | $379K | Hold |
1,250
| – | – | 0.06% | 130 |
|
|
2023
Q1 | $330K | Hold |
1,250
| – | – | 0.06% | 115 |
|
|
2022
Q4 | $300K | Sell |
1,250
-30
| -2% | -$6.72K | 0.06% | 151 |
|
|
2022
Q3 | $235K | Buy |
1,280
+30
| +2% | +$5.98K | 0.03% | 298 |
|
|
2022
Q2 | $210K | Hold |
1,250
| – | – | 0.03% | 332 |
|
|
2022
Q1 | $313K | Sell |
1,250
-250
| -17% | -$62.8K | 0.04% | 283 |
|
|
2021
Q4 | $385K | Buy |
+1,500
| New | +$367K | 0.05% | 263 |
|
|
2021
Q3 | – | Sell |
-1,000
| Closed | -$207K | – | 491 |
|
|
2021
Q2 | $207K | Buy |
+1,000
| New | +$204K | 0.02% | 330 |
|
|
2021
Q1 | – | Sell |
-1,500
| Closed | -$247K | – | 427 |
|
|
2020
Q4 | $247K | Sell |
1,500
-1,000
| -40% | -$146K | 0.04% | 234 |
|
|
2020
Q3 | $312K | Hold |
2,500
| – | – | 0.06% | 148 |
|
|
2020
Q2 | $243K | Buy |
+2,500
| New | +$260K | 0.06% | 139 |
|
|
2019
Q4 | – | Sell |
-2,000
| Closed | -$241K | – | 205 |
|
|
2019
Q3 | $241K | Buy |
2,000
+500
| +33% | +$64.6K | 0.03% | 149 |
|
|
2019
Q2 | $203K | Buy |
+1,500
| New | +$190K | 0.02% | 162 |
|
|
2017
Q2 | – | Sell |
-2,500
| Closed | -$222K | – | 172 |
|
|
2017
Q1 | $222K | Sell |
2,500
-1,000
| -29% | -$83.4K | 0.02% | 137 |
|
|
2016
Q4 | $259K | Hold |
3,500
| – | – | 0.03% | 125 |
|
|
2016
Q3 | $265K | Hold |
3,500
| – | – | 0.03% | 136 |
|
|
2016
Q2 | $270K | Hold |
3,500
| – | – | 0.04% | 146 |
|
|
2016
Q1 | $273K | Hold |
3,500
| – | – | 0.03% | 138 |
|
|
2015
Q4 | $237K | Hold |
3,500
| – | – | 0.03% | 155 |
|
|
2015
Q3 | $271K | Buy |
3,500
+1,000
| +40% | +$88.5K | 0.04% | 139 |
|
|
2015
Q2 | $227K | Buy |
+2,500
| New | +$200K | 0.03% | 152 |
|
Other funds holding HCA
Gabelli & Co Investment Advisers's HCA Position: Q2 2026 in Review
Gabelli & Co Investment Advisers sold out of HCA Healthcare (HCA) in Q2 2026, closing a stake of 500 shares — an estimated $237K sold.
Gabelli & Co Investment Advisers first reported a position in HCA in Q2 2015 and held it in 29 quarters. The position peaked at $406K in Q4 2023. 1,331 funds tracked by Wall St. Rank hold HCA as of Q2 2026.
- Gabelli & Co Investment Advisers reported no remaining HCA Healthcare position as of Q2 2026 after selling out during the quarter.
- Gabelli & Co Investment Advisers sold 500 HCA Healthcare shares in Q2 2026, an estimated $237K.
- Gabelli & Co Investment Advisers first reported a position in HCA Healthcare in Q2 2015 and held it in 29 quarters.
- Gabelli & Co Investment Advisers's HCA Healthcare position peaked at $406K in Q4 2023.
- 1,331 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.
Based on Gabelli & Co Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.